Cargando…
Social consequences and genetics for the child with overweight and obesity: An obesity medicine association (OMA) clinical practice statement 2022
BACKGROUND: This Obesity Medicine Association (OMA) clinical practice statement (CPS) covers two topics: 1) genetics and 2) social consequences for the child with overweight and obesity. This CPS is intended to provide clinicians with an overview of clinical practices applicable to children and adol...
Autores principales: | Cuda, Suzanne, Censani, Marisa, Kharofa, Roohi, Williams, Dominique R., O'Hara, Valerie, Karjoo, Sara, Paisley, Jennifer, Browne, Nancy T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662046/ https://www.ncbi.nlm.nih.gov/pubmed/37990726 http://dx.doi.org/10.1016/j.obpill.2022.100032 |
Ejemplares similares
-
Medication-induced weight gain and advanced therapies for the child with overweight and obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement 2022
por: Cuda, Suzanne, et al.
Publicado: (2022) -
Corrigendum to “Social consequences and genetics for the child with overweight and obesity: An obesity medicine association (OMA) clinical practice statement 2022” [Obes. Pillars 3 (2022) 100032]
por: Cuda, Suzanne, et al.
Publicado: (2022) -
Metabolic, behavioral health, and disordered eating comorbidities associated with obesity in pediatric patients: An Obesity Medical Association (OMA) Clinical Practice Statement 2022
por: Cuda, Suzanne E., et al.
Publicado: (2022) -
Assessment, differential diagnosis, and initial clinical evaluation of the pediatric patient with obesity: An Obesity Medical Association (OMA) Clinical Practice Statement 2022
por: Cuda, Suzanne E., et al.
Publicado: (2022) -
Clinical review: Guide to pharmacological management in pediatric obesity medicine
por: O'Hara, Valerie, et al.
Publicado: (2023)